Literature DB >> 12125101

Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor.

J Campión1, B Maestro, S Molero, N Dávila, M C Carranza, C Calle.   

Abstract

In an earlier study, we have reported an inhibition of insulin receptor (IR) mRNA levels and insulin binding by aldosterone in U-937 human promonocytic cells. In the present extension of our studies, we demonstrate that this inhibition by aldosterone had no effects on basal glucose transport or on basal thymidine incorporation into DNA, while the cell responsiveness reflected by the maximal response to insulin was decreased by 23% for glucose transport and by 31% for DNA synthesis after the aldosterone treatment. We also prove that this inhibition of the insulin response by aldosterone is mediated by a downregulation of the levels of mineralocorticoid receptors (MRs) (50% decrease) and their mRNA (50% decrease). In addition, the mineralocorticoid antagonist spironolactone reversed the decrease in MR mRNA levels elicited by aldosterone, which suggests the involvement of this receptor in the process. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125101     DOI: 10.1002/cbf.970

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  7 in total

Review 1.  The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update.

Authors:  Guido Lastra-Gonzalez; Camila Manrique-Acevedo; James R Sowers
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

Review 2.  The effect of aldosterone on glucose metabolism.

Authors:  Dalila B Corry; Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 3.  The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.

Authors:  Atsuhisa Sato
Journal:  Hypertens Res       Date:  2015-03-12       Impact factor: 3.872

4.  Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat.

Authors:  Jayaraman Selvaraj; Sampath Sathish; Chinnaiyan Mayilvanan; Karundevi Balasubramanian
Journal:  Mol Cell Biochem       Date:  2012-09-25       Impact factor: 3.396

Review 5.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

6.  Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.

Authors:  Dileep V Menon; Debbie Arbique; Zhongyun Wang; Beverley Adams-Huet; Richard J Auchus; Wanpen Vongpatanasin
Journal:  J Clin Endocrinol Metab       Date:  2009-01-21       Impact factor: 5.958

Review 7.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.